Menu

Condensin Folds DNA Through Loop Extrusion

By observing the activity of a protein complex in real time, researchers have uncovered new evidence for a long-standing theory.

Jun 1, 2018
Diana Kwon

ASYMMETRY: Researchers anchored a DNA strand to a quartz surface using streptavidin and watched as the protein complex condensin latched to the nucleic acid and formed loops. Contrary to previously established computational models of loop extrusion, which predicted that the two sides of the DNA strand would be reeled in simultaneously, findings from this study suggest that condensin anchors itself to a piece of DNA and reels in the other side.
See full infographic: WEB
© IKUMI KAYAMA/STUDIO KAYAMA

EDITOR’S CHOICE IN CELL & MOLECULAR BIOLOGY

The paper
M. Ganji et al., “Real-time imaging of DNA loop extrusion by condensin,” Science, doi:10.1126/science.aar7831, 2018.

How does a human cell neatly pack more than 2 meters’ worth of DNA into 46 tiny chromosomes? One popular theory is that, with the help of a large protein complex known as condensin, DNA forms many compact loops.

One of the earliest pieces of evidence for this process arrived in the 1970s, when a pair of biochemists observed loops of DNA in electron micrographs of HeLa chromosomes. Researchers later pinpointed condensin as a key protein complex involved in forming these structures, yet “how it works has been completely unknown,” says Christian Häring, who investigates chromosome structure and dynamics at the European Molecular Biology Laboratory in Germany. Some scientists have proposed that condensin binds to DNA and extrudes looped strands, but no one had directly observed the phenomenon.

To try to catch condensin in the act, Häring and his colleagues tethered a long piece of biotin-tipped DNA to a quartz surface covered in streptavidin, anchoring the two ends of the strand in a microfluidic chamber. Then, they stained the DNA with a bright-orange dye and added a buffer, fluorescently labeled yeast condensin, and ATP. Watching through a microscope, the researchers saw that condensin gradually pulled the DNA into a loop, drawing on just one side of the strand. “A single condensin would grab on [to the strand], and like a motor, asymmetrically start reeling in the DNA,” explains study coauthor Cees Dekker, a biophysicist at Delft University of Technology in the Netherlands.

“I was surprised,” says Häring. “I’ve been very skeptical that condensin could be this loop-extruding enzyme, because if you look at its structure, it’s not obvious how it could work as a motor that pushes out the DNA.” He adds that the details remain a bit of a mystery, which he and his colleagues plan to tackle next.

“It was really great to see [loop extrusion] happening in real time,” says Camilla Björkegren, a cell and tumor biologist at the Karolinska Institute in Sweden who wasn’t involved in the work. However, she notes, it’s not clear whether or how the process might work within cells, where the nucleic acid is wrapped into nucleosomes by histone proteins.

At least one scientist remains unconvinced that the new study proves the loop extrusion hypothesis. Biochemist Frank Uhlmann of the Francis Crick Institute in the U.K. who is collaborating with the coauthors on similar experiments but was not involved in this study says it’s too early to rule out alterative theories of condensin’s activity. For example, he and his colleagues proposed a model in which the protein complex binds to and stabilizes spontaneously forming loop structures rather than squeezing out new ones. Uhlmann says he’d like to see observations of more DNA-condensin interactions; for now, he adds, what the protein complex is actually doing remains “an exciting, open question.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.